Interprofessional Issues Novel, Interprofessional Approach Enhances Bed Assignments for Individuals on Antineoplastic Drugs in a Hospital Setting August 22, 2024
Nurse Empowerment Sharing Our Stories Supports, Celebrates, and Advances the Nursing Profession July 04, 2024
Trending Topics Research Safety Nurse Well-Being Drug Reference Sheets ONS Congress Specific Populations View All Topics
U.S. Food and Drug Administration (FDA) FDA Warns Not to Use Cardinal Health Monoject Syringes With Syringe Pumps and PCA Pumps November 21, 2023
U.S. Food and Drug Administration (FDA) FDA Announces B. Braun Medical, Inc.’s, Recall of Infusomat Space Large Volume Wireless and Non-Wireless Pumps November 20, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer With Biochemical Recurrence November 17, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab With Chemotherapy for HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma November 16, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Capivasertib With Fulvestrant for Breast Cancer November 16, 2023
Lung Cancer American Cancer Society Expands Eligibility in Updated Lung Cancer Screening Guideline November 16, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Repotrectinib for ROS1-Positive Non-Small Cell Lung Cancer November 15, 2023
U.S. Food and Drug Administration (FDA) FDA Reports Fresenius Medical Care’s Recall of Sanxin Single-Use Syringes November 15, 2023
Oncology Nurse Researcher Current AI Studies in Oncology Nursing Lack Evidence of Ethics and Efficacy November 15, 2023
Clinical Practice Standardizing Venous Access Assessment and Validating Safe Chemo Administration Drastically Lowers Rates of Adverse Venous Events November 14, 2023
U.S. Food and Drug Administration (FDA) FDA Amends Pembrolizumab’s Gastric Cancer Indication November 09, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Fruquintinib in Refractory Metastatic Colorectal Cancer November 09, 2023
Safety FDA Announces Teleflex and Arrow International’s Recall of Mislabeled Pressure Injectable Catheter Kits November 09, 2023
Interprofessional Teams SWAT Teams and Other Strategies to Maintain Difficult Central Lines and Dressings November 09, 2023
Clinical Practice OFS, Examestane Improve Recurrence-Related Outcomes in Premenopausal Breast Cancer November 08, 2023
U.S. Food and Drug Administration (FDA) Do Not Use Certain Brands of Saline and Sterile Water Medical Products From Nurse Assist Because They May Not Be Sterile, FDA Warns November 06, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Pembrolizumab With Chemotherapy for Biliary Tract Cancer November 01, 2023
Safety 10 Ways to Control Your Personal Safety and Minimize Your Risk for Workplace Violence November 01, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Toripalimab-Tpzi for Nasopharyngeal Carcinoma October 31, 2023
U.S. Food and Drug Administration (FDA) FDA Announces Exela’s Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 ml, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 ml, and Cysteine Hydrochloride Injection, USP 500 mg/10 ml October 29, 2023
Nurse Well-Being Create Space Between Work and Life With These ONS Member-Tested Techniques October 27, 2023
Breast Cancer Race, Age, Chemo, and Other Factors Increase Patients’ Risk for Breast Cancer–Related Lymphedema October 25, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Ivosidenib for Myelodysplastic Syndrome October 24, 2023
U.S. Food and Drug Administration (FDA) FDA Expands Pediatric Indication for Entrectinib and Approves New Pellet Formulation October 20, 2023
Breast Cancer AI Mammography Cancer Detection Rates Equivalent to Radiologist Readings October 18, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Neoadjuvant and Adjuvant Pembrolizumab for Resectable NSCLC October 17, 2023
Genetics & Genomics Uncover Clues About Potential Germline Risk in Somatic Tumor Testing Reports October 17, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Nivolumab for Adjuvant Treatment of Stage IIB/C Melanoma October 16, 2023
Nurse Empowerment Filipino American History Month Shines Light on the Contributions and Challenges of a Committed Community of Nurses October 16, 2023
Advanced Practice Nursing (APRN) Here’s How Oncology APPs Can Move Cardio-Oncology Care Upstream October 12, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Encorafenib With Binimetinib for Metastatic NSCLC With a BRAF V600E Variant October 12, 2023
Cancer Health Disparities Social Determinants Have Clinically Meaningful Effects on Breast Cancer Outcomes October 11, 2023
Nurse Well-Being Empower Your Professional Conversations With This Communication Approach October 10, 2023
U.S. Food and Drug Administration (FDA) Hospira, Inc., Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate, 1% and 2% Lidocaine HCl Injections, USP October 05, 2023
Cancer Research Discoveries in Race-Related Breast Cancer Biomarkers May Improve Precision Treatments October 04, 2023
U.S. Food and Drug Administration (FDA) FDA Safety Communication Provides Recommendations for Certain O&M Halyard Surgical N95 Respirators, Surgical Masks, and Pediatric Face Masks October 02, 2023
Cancer Healthcare Advocacy ONS Represents Voice of All Nurses in President’s Cancer Panel Stakeholder Meeting October 02, 2023
Nurse Well-Being Institutional Service Dogs Help Nurses With Their Practice and Well-Being September 28, 2023
ONS Leadership Develop the Next Generation of ONS’s Leadership by Applying for the LDC September 28, 2023
U.S. Food and Drug Administration (FDA) FDA Approves Bosutinib for Pediatric Patients With Chronic Myelogenous Leukemia September 27, 2023
U.S. Food and Drug Administration (FDA) VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1 g/10 ml September 27, 2023
Immunotherapy Cell-Based Therapy Shows Promise for Chemotherapy-Related Female Infertility September 27, 2023
U.S. Food and Drug Administration (FDA) Medline Industries Recalls One Lot of Hudson RCI AddiPak® Unit Dose Vial, 0.9% Full Normal Saline Solution September 25, 2023